Legend Biotech Corp Noncurrent Financial Assets Measured At Fair Value Through Other Comprehensive Income
Legend Biotech Corp (LEGN) had Noncurrent Financial Assets Measured At Fair Value Through Other Comprehensive Income of $5.00 million as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes › Equity
ifrs-full:NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome · last filed 2026-03-10
- 2025-12-31: Noncurrent Financial Assets Measured At Fair Value Through Other Comprehensive Income $5.00M.
- 2024-12-31: Noncurrent Financial Assets Measured At Fair Value Through Other Comprehensive Income $0.00.
| Period end | Noncurrent Financial Assets Measured At Fair Value Through Other Comprehensive Income |
|---|---|
| 2025-12-31 | $5.00M 20-F · filed 2026-03-10 |
| 2024-12-31 | $0.00 20-F · filed 2026-03-10 |